Skip to main content
Equibles
APVO logo

APVO · Aptevo Therapeutics Inc. · Investor Relations

Track APVO — free

Use APVO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research APVO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.80 +0.04 (+2.27%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“When considered in aggregate, these factors raise substantial doubt about our ability to continue as a going concern for the one-year period from the date of issuance of these financial statements.”
View the 10-Q filed Aug 14, 2026
Market Cap
$3.39M
Shares
1.80M
Volume · Oct 5 28.1K Avg daily vol (3M) 111.65K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Key facts CIK 1671584 CUSIP 03835L702 Visit website Investor relations